JPX · 7133.T
HYUGA PRIMARY CARE Co.,Ltd.
¥2,106-¥1 (-0.05%)
HYUGA PRIMARY CARE Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.05% below the high.
Loading market information…
JPX · 4524.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:16 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Morishita Jintan Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 8.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Morishita Jintan Co., Ltd.’s forward annual dividend is ¥65 per share, paid annual. The forward yield is 2.96% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Morishita Jintan Co., Ltd.’s next earnings report is currently expected on Nov 11, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Morishita Jintan Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Morishita Jintan Co., Ltd. is a Japanese enterprise that manufactures and distributes a diverse array of products, encompassing pharmaceuticals, quasi-pharmaceuticals, medical devices, and food items. The company's operations are divided into two main segments: Healthcare Business and Capsule Business. The Healthcare Business division is responsible for the production and sale of its proprietary Jintan branded goods, and also provides original equipment manufacturing (OEM) services for dietary supplements, cosmetic products, and various food items. Concurrently, the Capsule Business division handles both original equipment and design manufacturing (OEM/ODM) for pharmaceutical and food sectors, in addition to innovating and developing capsules for industrial applications. Established in 1893, the company's headquarters are located in Osaka, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥2,106-¥1 (-0.05%)
HYUGA PRIMARY CARE Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.05% below the high.
¥1,114+¥3 (+0.27%)
Create Medic Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 10.45% below the high.
¥1,727+¥6 (+0.35%)
Koken Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.32% below the high.
¥766+¥2 (+0.26%)
Mental Health Technologies Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 13.74% below the high.
¥27-¥1 (-3.57%)
Solasia Pharma K.K.’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
¥701-¥6 (-0.85%)
StemCell Institute Inc.’s quoted price sits in the lower half of its reported 52-week range, 28.18% below the high.
¥277-¥1 (-0.36%)
Softmax Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 33.41% below the high.
¥1,515¥0 (0.0%)
Nippon Chemiphar Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.42% below the high.
